These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20975265)

  • 21. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty.
    Yip HK; Wu CJ; Chang HW; Yang CH; Yu TH; Chen YH; Hang CL
    Chest; 2005 May; 127(5):1491-7. PubMed ID: 15888819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Alhadramy O; Westerhout CM; Brener SJ; Granger CB; Armstrong PW;
    Am Heart J; 2010 May; 159(5):899-904. PubMed ID: 20435202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of 1-year mortality with different measures of ST-segment recovery in all-comers after primary percutaneous coronary intervention for acute myocardial infarction.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Piek JJ; Tijssen JG; de Winter RJ
    Circ Cardiovasc Qual Outcomes; 2010 Sep; 3(5):522-9. PubMed ID: 20716716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of ST-segment elevation resolution in patients with ST-segment elevation acute myocardial infarction treated with primary or facilitated percutaneous coronary intervention.
    Palmerini T; De Servi S; Politi A; Martinoni A; Musumeci G; Ettori F; Piccaluga E; Sangiorgi D; Lauria G; Repetto A; Castiglioni B; Fabbiocchi F; Onofri M; De Cesare N; D'Urbano M; Poletti F; Sangiorgi G; Zanini R; Lettieri C; Belli G; Pirelli S; Klugmann S;
    Am J Cardiol; 2010 Mar; 105(5):605-10. PubMed ID: 20185004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    McLaughlin MG; Stone GW; Aymong E; Gardner G; Mehran R; Lansky AJ; Grines CL; Tcheng JE; Cox DA; Stuckey T; Garcia E; Guagliumi G; Turco M; Josephson ME; Zimetbaum P;
    J Am Coll Cardiol; 2004 Sep; 44(6):1215-23. PubMed ID: 15364322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction.
    Greenberg G; Assali A; Vaknin-Assa H; Brosh D; Teplitsky I; Fuchs S; Battler A; Kornowski R; Lev EI
    Am J Cardiol; 2010 Feb; 105(4):435-40. PubMed ID: 20152235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early reduction of QT dispersion after primary percutaneous intervention in ST-segment elevation acute myocardial infarction. Mechanisms and clinical implications.
    Jiménez-Candil J; Hernández Hernández J; Aguero VL; Martín A; Martín F; Moríñigo JL; Martín-Luengo C
    Cardiology; 2009; 113(3):172-9. PubMed ID: 19136825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
    Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of coronary collaterals on long-term prognosis in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.
    Desch S; de Waha S; Eitel I; Koch A; Gutberlet M; Schuler G; Thiele H
    Am J Cardiol; 2010 Sep; 106(5):605-11. PubMed ID: 20723632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic evaluation by clinical exercise test scores in patients treated with primary percutaneous coronary intervention or fibrinolysis for acute myocardial infarction (a Danish Trial in Acute Myocardial Infarction-2 Sub-Study).
    Valeur N; Clemmensen P; Grande P; Saunamäki K;
    Am J Cardiol; 2007 Oct; 100(7):1074-80. PubMed ID: 17884364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).
    Kotowycz MA; Cosman TL; Tartaglia C; Afzal R; Syal RP; Natarajan MK
    Am Heart J; 2010 Jan; 159(1):117.e1-6. PubMed ID: 20102876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Flynn A; Moscucci M; Share D; Smith D; LaLonde T; Changezi H; Riba A; Gurm HS
    Arch Intern Med; 2010 Nov; 170(20):1842-9. PubMed ID: 21059978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.